2019/2020年重要更新：胆囊癌的外科治疗
Essential updates 2019/2020: Surgical treatment of gallbladder cancer.
作者信息
Matsuyama Ryusei, Yabusita Yasuhiro, Homma Yuki, Kumamoto Takafumi, Endo Itaru
机构信息
Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
出版信息
Ann Gastroenterol Surg. 2021 Jan 29;5(2):152-161. doi: 10.1002/ags3.12434. eCollection 2021 Mar.
Abstract
Gallbladder cancer is a biliary tract cancer that originates in the gallbladder and cystic ducts and is recognized worldwide as a refractory cancer with early involvement of the surrounding area because of its anatomical characteristics. Although the number of cases is increasing steadily worldwide, the frequency of this disease remains low, making it difficult to plan large-scale clinical studies, and there is still much discussion about the indications for surgical resection and the introduction of multidisciplinary treatment. Articles published between 2019 and 2020 were reviewed, focusing mainly on the indications for surgical resection for each tumor stage, the treatment of incidental gallbladder cancer, and current trends in minimally invasive surgery for gallbladder cancer.
摘要
胆囊癌是一种起源于胆囊和胆囊管的胆道癌，由于其解剖学特征，在世界范围内被认为是一种难治性癌症，早期即可累及周围区域。尽管全球范围内病例数在稳步增加，但该疾病的发病率仍然较低，这使得开展大规模临床研究变得困难，并且关于手术切除的适应证以及多学科治疗的引入仍存在诸多讨论。对2019年至2020年发表的文章进行了综述，主要关注各肿瘤分期手术切除的适应证、意外胆囊癌的治疗以及胆囊癌微创手术的当前趋势。
相似文献
1
Essential updates 2019/2020: Surgical treatment of gallbladder cancer.
Ann Gastroenterol Surg. 2021 Jan 29;5(2):152-161. doi: 10.1002/ags3.12434. eCollection 2021 Mar.
2
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
BMC Cancer. 2020 Feb 14;20(1):122. doi: 10.1186/s12885-020-6610-4.
3
Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics.
World J Gastroenterol. 2022 May 14;28(18):1996-2007. doi: 10.3748/wjg.v28.i18.1996.
4
5
Managing the incidentally detected gallbladder cancer: algorithms and controversies.
Int J Surg. 2014;12 Suppl 2:S108-S119. doi: 10.1016/j.ijsu.2014.08.367. Epub 2014 Aug 23.
6
[Immediate radical re-resection of incidental T1b gallbladder cancer and the problem of an adequate extent of resection (results of the German Registry "Incidental Gallbladder Cancer")].
Zentralbl Chir. 2014 Dec;139 Suppl 2:e43-8. doi: 10.1055/s-0030-1262698. Epub 2011 Mar 1.
7
Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature.
Int J Surg Case Rep. 2022 Nov;100:107694. doi: 10.1016/j.ijscr.2022.107694. Epub 2022 Sep 21.
8
Laparoscopic radical hepatectomy and lymphadenectomy for incidental gallbladder cancer. Surgical technique with ICG fluorescence enhancement.
Surg Oncol. 2022 Jun;42:101756. doi: 10.1016/j.suronc.2022.101756. Epub 2022 Apr 4.
9
Anatomic location of residual disease after initial cholecystectomy independently determines outcomes after re-resection for incidental gallbladder cancer.
Langenbecks Arch Surg. 2021 Aug;406(5):1521-1532. doi: 10.1007/s00423-021-02165-1. Epub 2021 Apr 10.
10
Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Pol Przegl Chir. 2021 May 31;93(6):61-65. doi: 10.5604/01.3001.0015.3280.
引用本文的文献
1
Recent Trends in Surgical Strategies of Early-Stage Gallbladder Cancer: A Narrative Review.
J Clin Med. 2025 Aug 4;14(15):5483. doi: 10.3390/jcm14155483.
2
Neoadjuvant treatment for incidental gallbladder cancer: A systematic review.
Ann Hepatobiliary Pancreat Surg. 2025 May 31;29(2):113-120. doi: 10.14701/ahbps.24-223. Epub 2025 Mar 11.
3
A prospective observational study of laparoscopic approaches for suspected gallbladder cancer in Yamaguchi (YPB-002 LAGBY).
Updates Surg. 2025 Apr;77(2):435-445. doi: 10.1007/s13304-025-02119-y. Epub 2025 Feb 24.
4
Disease burden of biliary tract cancer in 204 countries and territories, 1990-2021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021.
Chin Med J (Engl). 2024 Dec 20;137(24):3117-3125. doi: 10.1097/CM9.0000000000003395. Epub 2024 Dec 17.
5
A case of successful conversion surgery for unresectable gallbladder cancer treated with durvalumab in combination with gemcitabine plus cisplatin.
Clin J Gastroenterol. 2025 Feb;18(1):161-168. doi: 10.1007/s12328-024-02053-3. Epub 2024 Oct 22.
6
Development and validation of a nomogram to predict overall survival in patients with incidental gallbladder cancer: A retrospective cohort study.
Front Oncol. 2023 Jan 24;12:1007374. doi: 10.3389/fonc.2022.1007374. eCollection 2022.
7
Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study.
Oncol Rep. 2023 Feb;49(2). doi: 10.3892/or.2023.8478. Epub 2023 Jan 12.
8
Differential diagnoses of gallbladder tumors using CT-based deep learning.
Ann Gastroenterol Surg. 2022 Jun 11;6(6):823-832. doi: 10.1002/ags3.12589. eCollection 2022 Nov.
9
Unveiling microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer.
Sci Rep. 2022 May 24;12(1):8766. doi: 10.1038/s41598-022-12658-8.
10
Oncologic Extended Resection of T3-Stage Incidental Gallbladder Carcinoma.
J Gastrointest Surg. 2022 Apr;26(4):991-992. doi: 10.1007/s11605-022-05252-w. Epub 2022 Jan 20.
本文引用的文献
1
Preoperative diagnoses and identification rates of unexpected gallbladder cancer.
PLoS One. 2020 Sep 18;15(9):e0239178. doi: 10.1371/journal.pone.0239178. eCollection 2020.
2
Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer.
Ann Surg Oncol. 2021 Jan;28(1):417-425. doi: 10.1245/s10434-020-09108-y. Epub 2020 Sep 5.
3
Feasibility and Safety of Laparoscopic Treatment for Early and T3 Stage Gallbladder Cancer: A Systematic Review.
Surg Laparosc Endosc Percutan Tech. 2020 Aug 17;31(1):113-123. doi: 10.1097/SLE.0000000000000852.
4
Examination of Prognostic Factors Affecting Long-Term Survival of Patients with Stage 3/4 Gallbladder Cancer without Distant Metastasis.
Cancers (Basel). 2020 Jul 27;12(8):2073. doi: 10.3390/cancers12082073.
5
Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.
Br J Surg. 2020 Sep;107(10):1334-1343. doi: 10.1002/bjs.11618. Epub 2020 May 26.
6
Oncologic safety of laparoscopic radical cholecystectomy in pT2 gallbladder cancer: A propensity score matching analysis compared to open approach.
Medicine (Baltimore). 2020 May;99(20):e20039. doi: 10.1097/MD.0000000000020039.
7
Comparison of lymph node evaluation and yield among patients undergoing open and minimally invasive surgery for gallbladder adenocarcinoma.
Surg Endosc. 2021 May;35(5):2223-2228. doi: 10.1007/s00464-020-07635-z. Epub 2020 May 19.
8
Robotic extended cholecystectomy in gallbladder cancer.
Surg Endosc. 2020 Jul;34(7):3256-3261. doi: 10.1007/s00464-020-07554-z. Epub 2020 Apr 18.
9
Surgical Indication for Advanced Gallbladder Cancer Considering the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
Dig Surg. 2020;37(5):390-400. doi: 10.1159/000506628. Epub 2020 Apr 9.
10
Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013).
Cancer Med. 2020 Jun;9(11):3668-3679. doi: 10.1002/cam4.2989. Epub 2020 Mar 31.
Zotero 插件